Valuation GlaxoSmithKline plc LIQUIDNET SYSTEMS

Stocks

Delayed LIQUIDNET SYSTEMS Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-

Jul. 30	Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US	RE
Jul. 30	GSK global supply chain director sells 38,000 shares	AN

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	77,395	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	5.73%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	95,160	91,916	88,654
Change	-	-24.65%	-1.89%	-8.24%	28.83%	8.56%	-3.41%	-3.55%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	12.7x	11.3x	10.8x
PBR	5.34x	5.47x	4.4x	4.02x	-	5x	3.91x	3.38x
PEG	-	0x	-0.2x	-0.4x	0x	1.65x	0.9x	2.69x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.28x	2.17x	2.1x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.8x	2.58x	2.41x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.24x	7.3x	6.83x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.26x	8.23x	7.62x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	14.5x	14.3x	13.1x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.9%	6.98%	7.61%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7315	0.7632
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.6%	3.79%	3.95%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.519	1.712	1.781
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	45.8%	42.7%	42.9%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,989	35,618	36,795
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,555	12,592	12,982
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,273	11,163	11,632
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,171	6,958	7,126
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	17,765	14,520	11,259
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.32	19.32	19.32
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,007,011	-	-
Announcement Date	2/9/22	2/1/23	1/31/24	2/5/25	2/4/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.03x	12.19x	25.61x	0.59%	1,024B
JOHNSON & JOHNSON	27.48x	6.29x	17.54x	2.1%	618B
ABBVIE INC.	32.57x	7.42x	15.35x	2.76%	443B
ROCHE HOLDING AG	19.7x	4.68x	11.59x	2.83%	349B
ASTRAZENECA PLC	21.76x	4.48x	12.7x	1.96%	264B
NOVO NORDISK A/S	13.48x	5.05x	10.4x	3.71%	209B
AMGEN INC.	25.29x	6.61x	11.66x	2.62%	208B
GILEAD SCIENCES, INC.	-46.92x	5.63x	31.08x	2.53%	162B
PFIZER INC.	12.69x	3.11x	7.86x	6.88%	143B
Average	15.68x	6.16x	15.98x	2.89%	379.88B
Weighted average by Cap.	24.04x	7.68x	18.14x	2.14%